Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB402211

AGTR-1 Antibody (1010103) [DyLight 350], Novus Biologicals™
SDP

Catalog No. NB402211 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB402211 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB402211 Supplier Novus Biologicals Supplier No. FAB10244D
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

AGTR-1 Monoclonal antibody specifically detects AGTR-1 in Human samples. It is validated for Flow Cytometry, CyTOF

Specifications

Antigen AGTR-1
Applications Flow Cytometry, CyTOF
Classification Monoclonal
Clone 1010103
Conjugate DyLight 350
Dilution Flow Cytometry, CyTOF-ready
Formulation 50mM Sodium Borate
Gene Alias AG2S, AGTR1AAngiotensin II type-1 receptor, Angiostensin Receptor, angiotensin II receptor, type 1, angiotensin receptor 1, angiotensin receptor 1B, AT1AT1AR, AT1B, AT1R, AT2R1A, AT2R1AGTR1B, AT2R1BAT1BR, HAT1R, type-1 angiotensin II receptor, type-1B angiotensin II receptor
Host Species Mouse
Immunogen Synthetic peptide containing human AGTR-1
Purification Method Protein A or G purified from hybridoma culture supernatant
Quantity 0.1 mL
Regulatory Status RUO
Research Discipline GPCR
Primary or Secondary Primary
Gene ID (Entrez) 185
Target Species Human
Content And Storage Store at 4°C in the dark.
Form Purified
Isotype IgG2b
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.